Exact Mass: 257.101166

Exact Mass Matches: 257.101166

Found 35 metabolites which its exact mass value is equals to given mass value 257.101166, within given mass tolerance error 1.6E-6 dalton. Try search metabolite list with more accurate mass tolerance error 3.2E-7 dalton.

5-Methylcytidine

5-Methylcytidine

C10H15N3O5 (257.101166)


CONFIDENCE standard compound; INTERNAL_ID 322 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.

   

5-Methylcytidine

4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one

C10H15N3O5 (257.101166)


5-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 5-Methylcytidine is a post-transcriptional modifications found in tRNA, snRNA, and rRNA. It is associated with the genetic change which is involved in the origin of cancer (PMID 6260434). [HMDB] 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.

   

Pyro-L-glutaminyl-L-glutamine

(2S)-4-carbamoyl-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}butanoic acid

C10H15N3O5 (257.101166)


Pyro-L-glutaminyl-L-glutamine is found in fruits. Pyro-L-glutaminyl-L-glutamine is a constituent of the seeds of Dolichos biflorus (papadi). Constituent of the seeds of Dolichos biflorus (papadi). Pyro-L-glutaminyl-L-glutamine is found in fruits.

   

3-Methylcytidine

3-Methylcytidine

C10H15N3O5 (257.101166)


3-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. These are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 3-Methylcytidine is a potential urinary biomarker of whole grain intake (PMID: 27805021). 3-Methylcytidine has been identified in the human placenta (PMID: 32033212). 3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].

   

1-[(2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one

1-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methyl-1,2,3,4-tetrahydropyrimidin-2-one

C10H15N3O5 (257.101166)


   

2'-O-Methylcytidine

1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-4-imino-1,4-dihydropyrimidin-2-ol

C10H15N3O5 (257.101166)


2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].

   

2'-C-Methylcytidine

4-amino-1-(3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one

C10H15N3O5 (257.101166)


   

benserazide

2-amino-3-hydroxy-N-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazonic acid

C10H15N3O5 (257.101166)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

4-Amino-1-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one

C10H15N3O5 (257.101166)


   

benserazide

2-Amino-3-hydroxy-2-(2,3,4-trihydroxybenzyl)propionohydrazide

C10H15N3O5 (257.101166)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2853

   

2-deoxy-5-(hydroxymethyl)cytidine

2-deoxy-5-(hydroxymethyl)cytidine

C10H15N3O5 (257.101166)


   
   
   

3-Methylcytidine

3-Methylcytidine

C10H15N3O5 (257.101166)


3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].

   

5-Hydroxymethyldeoxycytidin|O5-hydroxymethyl-2-deoxy-cytidine

5-Hydroxymethyldeoxycytidin|O5-hydroxymethyl-2-deoxy-cytidine

C10H15N3O5 (257.101166)


   

N-(beta-Glutaminylaminoethyl)-2H-Oxo-5(4H)-Isoxazolone

N-(beta-Glutaminylaminoethyl)-2H-Oxo-5(4H)-Isoxazolone

C10H15N3O5 (257.101166)


   

2-O-Methylcytidine

2′-O-methylcytidine

C10H15N3O5 (257.101166)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.052 2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].

   

3-O-Methylcytidine

3-(O-METHYL)CYTIDINE

C10H15N3O5 (257.101166)


3′-O-Methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

   
   

5-Hydroxymethyl-deoxycytidine

5-Hydroxymethyl-deoxycytidine

C10H15N3O5 (257.101166)


   
   

Pyro-L-glutaminyl-L-glutamine

4-carbamoyl-2-[(5-oxopyrrolidin-2-yl)formamido]butanoic acid

C10H15N3O5 (257.101166)


   

2-C-Methylcytidine

2-C-Methylcytidine

C10H15N3O5 (257.101166)


NM107 (2'-C-Methylcytidine) is an nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, the EC50 of NM107 in the wild-type replicon cells is 1.85 μM[1][2].

   

5-Methylisocytidine

5-Methylisocytidine

C10H15N3O5 (257.101166)


   

4-Amino-5-methyl-1-pentofuranosyl-2(1h)-pyrimidinone

4-Amino-5-methyl-1-pentofuranosyl-2(1h)-pyrimidinone

C10H15N3O5 (257.101166)


   

4-Amino-1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one

4-Amino-1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one

C10H15N3O5 (257.101166)


   

N4-Methylcytidine

N4-Methylcytidine

C10H15N3O5 (257.101166)


N4-Methylcytidine (Nsc518744) is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

   

5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid

5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid

C10H15N3O5 (257.101166)


   

Pyroglutamylglutamine

Pyroglutamylglutamine

C10H15N3O5 (257.101166)


A dpeptide obtained by formal condensation of the carboxy group of L-pyroglutamine with the amino group of L-glutamine

   
   
   
   

(2s)-2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H15N3O5 (257.101166)


   

2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C10H15N3O5 (257.101166)